{
    "eid": "2-s2.0-85137931909",
    "title": "Pyridostigmine-induced coronary artery spasm in early-onset myasthenia gravis: a case presentation and review of the literature",
    "cover-date": "2022-09-14",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (all)",
            "@code": "2700",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "Arrhythmias",
        "Ischaemic heart disease",
        "Neurology (drugs and medicines)",
        "Neuromuscular disease",
        "Unwanted effects / adverse reactions"
    ],
    "authors": [
        "Oranuch Chuapakdee",
        "Tanit Layangkool",
        "Nonthikorn Theerasuwipakorn"
    ],
    "citedby-count": 0,
    "ref-count": 13,
    "ref-list": [
        "Coronary vasospasm secondary to hypercholinergic crisis: An iatrogenic cause of acute myocardial infarction in myasthenia gravis",
        "Non-coronary myocardial infarction in myasthenia gravis: Case report and review of the literature",
        "Multimodality imaging in chest pain",
        "Rare case of iatrogenic myocardial infarction induced by use of pyridostigmine",
        "Life-threatening ventricular arrhythmias in patients with silent myocardial ischemia due to coronary-artery spasm",
        "Acute myocardial infarction with normal coronary arteries: Role of coronary artery spasm and arrhythmic complications",
        "Mechanisms of coronary artery spasm",
        "Induction of coronary artery spasm by acetylcholine in patients with variant angina: Possible role of the parasympathetic nervous system in the pathogenesis of coronary artery spasm",
        "Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries",
        "Myasthenia gravis and Lambert-Eaton myasthenic syndrome",
        "Clinical characteristics of female patients with coronary spastic angina: Comparison with male patients",
        "International consensus guidance for management of myasthenia gravis: 2020 update",
        "Influence of calcium antagonist drugs in myasthenia gravis in the elderly"
    ],
    "affiliation": [
        {
            "affiliation-city": "Ubon Ratchathani",
            "@id": "125781648",
            "affilname": "Sunpasithiprasong Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125781648",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}